QQ客服 官方微博 反馈留言

	Rational Design of Selenadiazole Derivatives to Antagonize Hyperglycemia-Induced Drug Resistance in Cancer Cells
	Liu, Yuedan[1]; Luo, Yi[1]; Li, Xiaoling[1]; Zheng, Wenjie[1]; Chen, Tianfeng[1]
	2015
卷号	10期号:[db:dc_citation_issue]页码:642
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3332597
专题	暨南大学
作者单位	[1]Jinan Univ, Dept Chem, Guangzhou 510631, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Liu, Yuedan[1],Luo, Yi[1],Li, Xiaoling[1],et al. Rational Design of Selenadiazole Derivatives to Antagonize Hyperglycemia-Induced Drug Resistance in Cancer Cells[J],2015,10([db:dc_citation_issue]):642.
APA	Liu, Yuedan[1],Luo, Yi[1],Li, Xiaoling[1],Zheng, Wenjie[1],&Chen, Tianfeng[1].(2015).Rational Design of Selenadiazole Derivatives to Antagonize Hyperglycemia-Induced Drug Resistance in Cancer Cells.,10([db:dc_citation_issue]),642.
MLA	Liu, Yuedan[1],et al."Rational Design of Selenadiazole Derivatives to Antagonize Hyperglycemia-Induced Drug Resistance in Cancer Cells".10.[db:dc_citation_issue](2015):642.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。